NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
NIST and collaborators have developed a new line of mAb-producing living cells that can help manufacturers better understand how their ...
NIST and collaborators have developed a new line of mAb-producing living cells that can help manufacturers better understand how their ...
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) working with industry partners are among the first ...
An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according ...
The U.S. Department of Health and Human Services (HHS) announced on Feb 10. it will acquire 600,000 treatment courses of ...
After screening a large, diverse library of synthetic nanobodies, Sandia researchers identified and evaluated several potent nanobodies that can protect ...
Researchers working in a BSL-3 lab at the Washington University School of Medicine in St. Louis have identified an antibody ...
Hundreds of antibodies contributed by over 50 different organizations around the world were classified and mapped. This study shows exactly ...
The U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase 1.4 million additional ...
Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have confirmed that monoclonal antibodies can ...
Naval Medical Center San Diego (NMCSD) administered the hospital’s first monoclonal antibody (mAb) treatment to a COVID-19-positive patient Jan. 26. ...
Based on the recommendation of the independent data monitoring committee (IDMC), Regeneron Pharmaceuticals has stopped enrolling patients receiving advanced COVID-19 care ...
The U.S. Food and Drug Administration this week approved Inmazeb, previously called REGN-EB3, a mixture of three monoclonal antibodies made ...
Researchers from the U.S. Army Futures Command, in collaboration with Houston Methodist, Pennsylvania State University, and UT Austin, tested alternative ...
Eli Lilly and Company today announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy ...
The National Institutes of Health has issued an urgent funding opportunity announcement to invite applications to repurpose existing therapeutic agents ...
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials An antibody first identified in a blood ...
Scientists reveal potential coronavirus therapy using structural biology and the Advanced Light Source As scientists across the globe race to ...
A Special Emphasis Panel of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of ...
Alexion Pharmaceuticals Inc. announced today it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients ...
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...